IRS funding, Alzheimer’s drug

Air Date:
Heard On Central Time
A check from the IRS sits on a table with crucial information covered with an envelope
In this April 23, 2020, photo, President Donald Trump’s name is seen on a stimulus check issued by the IRS to help combat the adverse economic effects of the COVID-19 outbreak. Eric Gay/AP Photo

We talk to a researcher about the Biden administration’s expanded IRS funding and why House Republicans want to rescind it. Then, a doctor helps us better understand a new drug treatment for early Alzheimer’s.

Featured in this Show

  • Why House Republicans voted to rescind IRS funding

    As their first order of business after electing a speaker, Republicans in the House of Representatives voted to rescind tens of billions of dollars of funding for the IRS. We talk about the original sum of funding and its intended purpose, and how the agency could falter if further defending efforts succeed.

  • FDA approves drug to help with early Alzheimer's

    The Food and Drug Administration approved a drug called lecanemab to be used for people with early Alzheimer’s in an effort to slow the cognitive decline of the disease. A geriatrician joins us to talk about the drug.

Episode Credits

  • Rob Ferrett Host
  • Sarah Hopefl Technical Director
  • Tim Peterson Producer
  • Emilie Burditt Producer
  • Steven Rosenthal Guest
  • Dr. Nathaniel Chin Guest

Related Stories